Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Yoshinobu Onuma; Bernard Chevalier; Masafumi Ono; Ángel Cequier; Dariusz Dudek; Michael Haude; Didier Carrié; Manel Sabaté; Stephan Windecker; Richard Rapoza; Nick E.J. West; Sebastian Reith; Manuel de Sousa Almeida; Gianluca Campo; Andrés Íñiguez; Patrick W. Serruys

doi:10.4244/eij-d-20-00024

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

EuroIntervention 16(11): e938-e941

Article 2020 English

Related publications

Article2018

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Patrick W. Serruys, Bernard Chevalier

Journal of the American College of Cardiology

Article2015

ACUTE RECOIL FOLLOWING IMPLANTATION OF EVEROLIMUS-ELUTING ABSORB BIODEGRADABLE VASCULAR SCAFFOLDS OR XIENCE METALLIC STENTS: THE ABSORB II TRIAL

Bernard Chevalier, Yuki Ishibashi, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Letter2018

The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

Yuki Katagiri, Patrick W. Serruys, Carlos Macaya, John A. Ormiston, Jonathan Hill, Iréne Lang, Mohaned Egred, Jean Fajadet, Maciej Lesiak, Joanna J. Wykrzykowska, Jan J. Piek, Manel Sabaté, Stephan Windecker, Bernard Chevalier, Yoshinobu Onuma

КАРДИОЛОГИЯ УЗБЕКИСТАНА

Article2014

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

Bernard De Bruyne, Gábor G. Tóth, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2016

TCT-415 Absorb Bioresorbable Vascular Scaffolds vs. XIENCE Everolimus-Eluting Stents: Are Clinical Outcomes Different for Men and Women?

Dean J. Kereiakes, Stephen G. Ellis, Runlin Gao, Takeshi Kimura, Yoshinobu Onuma, Karine Piard‐Ruster, Yunlong Zhang, Kai Koo, Patrick W. Serruys, Gregg W. Stone

Journal of the American College of Cardiology

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Abstract

Discussion(0)

Related publications

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

ACUTE RECOIL FOLLOWING IMPLANTATION OF EVEROLIMUS-ELUTING ABSORB BIODEGRADABLE VASCULAR SCAFFOLDS OR XIENCE METALLIC STENTS: THE ABSORB II TRIAL

The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

TCT-415 Absorb Bioresorbable Vascular Scaffolds vs. XIENCE Everolimus-Eluting Stents: Are Clinical Outcomes Different for Men and Women?